Loading clinical trials...
Loading clinical trials...
The recurrent pancreatic cancer (Rec-PC) after radical surgery is sometimes eligible to clinical trial of chemotherapy for unresectable pancreatic cancer. However, the difference between Rec-PC and pr...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Kochi University
NCT07410676 · Cancer, Sarcoma, and more
NCT06752811 · Pancreatic Cancer Metastatic
NCT06922591 · PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, and more
NCT07201194 · Breast Cancer, Prostate Cancer, and more
NCT07040228 · Pancreatic Cancer Metastatic
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions